Parasitic central nervous system infections in immunocompromised hosts

Clinical Infectious Diseases

Volumn 40, Issue 7, 2005, Pages 1005-1015

  Walker, Melanie ^a   Zunt, Joseph R ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIRETROVIRUS AGENT; ARTEMETHER; BENZNIDAZOLE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; FOLINIC ACID; IVERMECTIN; NIFURTIMOX; OXAMNIQUINE; PRAZIQUANTEL; PYRIMETHAMINE; STEROID; SULFADIAZINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY DETECTION; BIOPSY; CENTRAL NERVOUS SYSTEM INFECTION; CHAGAS DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; HEART TRANSPLANTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LYMPHOCYTE COUNT; NEUROCYSTICERCOSIS; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITE TRANSMISSION; PRIORITY JOURNAL; REINFECTION; REVIEW; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SECONDARY PREVENTION; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TAENIA SOLIUM; TOXOPLASMA GONDII; TOXOPLASMOSIS; TRYPANOSOMA CRUZI; URINARY TRACT DISEASE;

CENTRAL NERVOUS SYSTEM INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; PARASITIC DISEASES;

EID: 15744385080     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/428621     Document Type: Review

References (129)

1. Sostak P, Padovan CS, Yousry TA, Ledderose G, Kolb HJ, Straube A. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 2003; 60:842-8.
2. Conti DJ, Rubin RH. Infection of the central nervous system in organ transplant recipients. Neurol Clin 1988; 6:241-60.
3. Graus F, Saiz A, Sierra J, et al. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology 1996; 46:1004-9.
4. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000; 30:1217-58.
5. Michaels MG, Wald ER, Fricker FJ, del Nido PJ, Armitage J. Toxoplasmosis in pediatric recipients of heart transplants. Clin Infect Dis 1992; 14:847-51.
6. Gonzalez MI, Caballero D, Lopez C, et al. Cerebral toxoplasmosis and Guillain-Barré syndrome after allogeneic peripheral stem cell transplantation. Transpl Infect Dis 2000; 2:145-9.
7. Blanche C, Aleksic I, Takkenberg JJ, Czer LS, Fishbein MC, Trento A. Heart transplantation for Chagas' cardiomyopathy. Ann Thorac Surg 1995; 60:1406-8; discussion 1408-9.
8. Altclas J, Sinagra A, Jaimovich G, et al. Reactivation of chronic Chagas' disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole. Transpl Infect Dis 1999; 1:135-7.
9. Vazquez MC, Sabbatiello R, Schiavelli R, et al. Chagas disease and transplantation. Transplant Proc 1996; 28:3301-3.
10. Gordillo-Paniagua G, Munoz-Arizpe R, Ponsa-Molina R. Unusual complication in a patient with renal transplantation: cerebral cysticercosis. Nephron 1987; 45:65-7.
11. Kayler LK, Rudich SM, Merion RM. Orthotopic liver transplantation from a donor with a history of schistosomiasis. Transplant Proc 2003; 35:2974-6.
12. Mahmoud KM, Sobh MA, El-Agroudy AE, et al. Impact of schistosomiasis on patient and graft outcome after renal transplantation: 10 years' follow-up. Nephrol Dial Transplant 2001; 16:2214-21.
13. Cordonnier C, Feuilhade F, Vernant JP, Marsault C, Rodet M, Rochant H. Cytomegalovirus encephalitis occurring after bone marrow transplantation. Scand J Haematol 1983; 31:248-52.
14. Patchell RA. Neurological complications of organ transplantation. Ann Neurol 1994; 36:688-703.
15. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338:1741-51.
16. Anders KH, Guerra WF, Tomiyasu U, Verity MA, Vinters HV. The neuropathology of AIDS: UCLA experience and review. Am J Pathol 1986; 124:537-58.
17. Ionita C, Wasay M, Balos L, Bakshi R. MR imaging in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant disease. AJNR Am J Neuroradiol 2004; 25:270-3.
18. Leiguarda R, Roncoroni A, Taratuto AL, et al. Acute CNS infection by Trypanosoma cruzi (Chagas' disease) in immunosuppressed patients. Neurology 1990; 40:850-1.
19. Di Lorenzo GA, Pagano MA, Taratuto AL, Garau ML, Meli FJ, Pomsztein MD. Chagasic granulomatous encephalitis in immunosuppressed patients: computed tomography and magnetic resonance imaging findings. J Neuroimaging 1996; 6:94-7.
20. Malheiros SM, Almeida DR, Massaro AR, et al. Neurologic complications after heart transplantation. Arq Neuropsiquiatr 2002; 60:192-7.
21. Silva N, O'Bryan L, Medeiros E, et al. Trypanosoma cruzi meningoencephalitis in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:342-9.
22. Gellido CL, Onesti S, Llena J, Suarez M. Spinal schistosomiasis. Neurology 2000; 54:527.
23. Junker J, Eckardt L, Husstedt I. Cervical intramedullar schistosomiasis as a rare cause of acute tetraparesis. Clin Neurol Neurosurg 2001; 103:39-42.
24. Preidler KW, Riepl T, Szolar D, Ranner G. Cerebral schistosomiasis: MR and CT appearance. AJNR Am J Neuroradiol 1996; 17:1598-600.
25. Vishwanath S, Baker RA, Mansheim BJ. Strongyloides infection and meningitis in an immunocompromised host. Am J Trop Med Hyg 1982; 31:857-8.
26. Morgello S, Soifer FM, Lin CS, Wolfe DE. Central nervous system Strongyloides stercoralis in acquired immunodeficiency syndrome: a report of two cases and review of the literature. Acta Neuropathol (Berl) 1993; 86:285-8.
27. Smallman LA, Young JA, Shortland-Webb WR, Carey MP, Michael J. Strongyloides stercoralis hyperinfestation syndrome with Escherichia coli meningitis: report of two cases. J Clin Pathol 1986; 39:366-70.
28. Martinez HR, Rangel-Guerra R, Elizondo G, et al. MR imaging in neurocysticercosis: a study of 56 cases. AJNR Am J Neuroradiol 1989; 10:1011-9.
29. Masdeu JC, Tantulavanich S, Gorelick PP, et al. Brain abscess caused by Strongyloides stercoralis. Arch Neurol 1982; 39:62-3.
30. Ramsey RG, Gean AD. Neuroimaging of AIDS. I. Central nervous system toxoplasmosis. Neuroimaging Clin N Am 1997; 7:171-86.
31. Sanelli PC, Lev MH, Gonzalez RG, Schaefer PW. Unique linear and nodular MR enhancement pattern in schistosomiasis of the central nervous system: report of three patients. AJR Am J Roentgenol 2001; 177:1471-4.
32. Alvarez JI, Colegial CH, Castano CA, Trujillo J, Teale JM, Restrepo BI. The human nervous tissue in proximity to granulomatous lesions induced by Taenia solium metacestodes displays an active response. J Neuroimmunol 2002; 127:139-44.
33. Lawrence RA. Immunity to filarial nematodes. Vet Parasitol 2001; 100:33-44.
34. Centers for Disease Control and Prevention (CDC). Laboratory diagnosis of parasites of public health concern. Atlanta, GA: CDC, 2003.
35. Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 1994; 19:402-8.
36. Baril L, Ancelle T, Goulet V, Thulliez P, Tirard-Fleury V, Carme B. Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scand J Infect Dis 1999; 31:305-9.
37. Israelski DM, Chmiel JS, Poggensee L, Phair JP, Remington JS. Prevalence of Toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitis. J Acquir Immune Defic Syndr 1993; 6:414-8.
38. Roghmann MC, Faulkner CT, Lefkowitz A, Patton S, Zimmerman J, Morris JG Jr. Decreased seroprevalence for Toxoplasma gondii in Seventh Day Adventists in Maryland. Am J Trop Med Hyg 1999; 60:790-2.
39. Contreras M, Schenone H, Salinas P, et al. Seroepidemiology of human toxoplasmosis in Chile. Rev Inst Med Trop Sao Paulo 1996; 38:431-5.
40. Luft BJ, Naot Y, Araujo FG, Stinson EB, Remington JS. Primary and reactivated toxoplasma infection in patients with cardiac transplants: cslinical spectrum and problems in diagnosis in a defined population. Ann Intern Med 1983; 99:27-31.
41. Slavin MA, Meyers JD, Remington JS, Hackman RC. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 1994; 13:549-57.
42. Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect 2002; 8:634-40.
43. Re D, Reiser M, Bamborschke S, et al. Two cases of toxoplasmic encephalitis in patients with acute T-cell leukaemia and lymphoma. J Infect 1999; 38:26-9.
44. Singh N, Gayowski T, Marino IR. Toxoplasma gondii pneumonitis in a liver transplant recipient: implications for diagnosis. Liver Transpl Surg 1996; 2:299-300.
45. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992; 327:1643-8.
46. Luft BJ, Remington JS. AIDS commentary: toxoplasmic encephalitis. J Infect Dis 1988; 157:1-6.
47. Bucher HC, Griffith L, Guyatt GH, Opravil M. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15:104-14.
48. Carr A, Tindall B, Brew BJ, et al. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992; 117:106-11.
49. Straathof CS, Kortbeek LM, Roerdink H, Sillevis Smitt PA, van den Bent MJ. A solitary spinal cord toxoplasma lesion after peripheral stem-cell transplantation. J Neurol 2001; 248:814-5.
50. Vyas R, Ebright JR. Toxoplasmosis of the spinal cord in a patient with AIDS: case report and review. Clin Infect Dis 1996; 23:1061-5.
51. Dietrich U, Maschke M, Dorfler A, Prumbaum M, Forsting M. MRI of intracranial toxoplasmosis after bone marrow transplantation. Neuroradiology 2000; 42:14-8.
52. Joseph P, Calderon MM, Gilman RH, et al. Optimization and evaluation of a PCR assay for detecting toxoplasmic encephalitis in patients with AIDS. J Clin Microbiol 2002; 40:4499-503.
53. Ferreira MS, Nishioka Sde A, Silvestre MT, Borges AS, Nunes-Araujo FR, Rocha A. Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature. Clin Infect Dis 1997; 25:1397-400.
54. Metze K, Maciel JA Jr. AIDS and Chagas' disease. Neurology 1993; 43:447-8.
55. Pautas para la prevencion de infecciones oportunistas en personas con VIH o SIDA en America Latina y el Caribe. Bol Oficina Sanit Panam 1996; 121:377-403.
56. Dictar M, Sinagra A, Veron MT, et al. Recipients and donors of bone marrow transplants suffering from Chagas' disease: management and preemptive therapy of parasitemia. Bone Marrow Transplant 1998; 21:391-3.
57. Kardaman MW, Amin MA, Fenwick A, Cheesmond AK, Dixon HG. A field trial using praziquantel (BiltricideR) to treat Schistosoma mansoni and Schistosoma haematobium infection in Gezira, Sudan. Ann Trop Med Parasitol 1983; 77:297-304.
58. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004; 17:208-17.
59. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004; 350:249-58.
60. Drugs for parasitic infections: the medical letter. New Rochelle, NY: The Medical Letter, 2002.
61. Masur H, Kaplan JE, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002: recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann Intern Med 2002; 137:435-78.
62. Del Brutto OH, Sotelo J, Roman GC. Therapy for neurocysticercosis: a reappraisal. Clin Infect Dis 1993; 17:730-5.
63. Montoya JG, Giraldo LF, Efron B, et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis 2001; 33:629-40.
64. Lappalainen M, Jokiranta TS, Halme L, et al. Disseminated toxoplasmosis after liver transplantation: case report and review. Clin Infect Dis 1998; 27:1327-8.
65. Mehta J, Powles R, Singhal S, Riley U, Treleaven J, Catovsky D. Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or marrow transplantation. Leuk Lymphoma 1997; 26:83-8.
66. Zeller V, Truffot C, Agher R, et al. Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis. Clin Infect Dis 2002; 34:662-7.
67. Fung HB, Kirschenbaum HL. Treatment regimens for patients with toxoplasmic encephalitis. Clin Ther 1996; 18:1037-56; discussion 1036.
68. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 2003; 98:577-91.
69. Dias JC, Silveira AC, Schofield CJ. The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz 2002; 97:603-12.
70. Leiby DA, Herron RM Jr, Read EJ, Lenes BA, Stumpf RJ. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002; 42:549-55.
71. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA 2003; 289:959-62.
72. Chagas disease after organ transplantation - United States, 2001. MMWR Morb Mortal Wkly Rep 2002; 51:210-12.
73. Antunes AC, Cecchini FM, Bolli FB, et al. Cerebral trypanosomiasis and AIDS. Arq Neuropsiquiatr 2002; 60:730-3.
74. Anez N, Carrasco H, Parada H, et al. Acute Chagas' disease in western Venezuela: a clinical, seroparasitologic, and epidemiologic study. Am J Trop Med Hyg 1999; 60:215-22.
75. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2001; 1:92-100.
76. Bestetti RB, Muccillo G. Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol 1997; 60:187-93.
77. Rocha A, de Meneses AC, da Silva AM, et al. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 1994; 50:261-8.
78. Kirchhoff LV. American trypanosomiasis (Chagas' disease) - a tropical disease now in the United States. N Engl J Med 1993; 329:639-44.
79. Leiby DA, Wendel S, Takaoka DT, Fachini RM, Oliveira LC, Tibbals MA. Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits. J Clin Microbiol 2000; 38:639-42.
80. Gomes ML, Galvao LM, Macedo AM, Pena SD, Chiari E. Chagas' disease diagnosis: comparative analysis of parasitologic, molecular, and serologic methods. Am J Trop Med Hyg 1999; 60:205-10.
81. Sousa AA, Lobo MC, Barbosa RA, Bello V. Chagas seropositive donors in kidney transplantation. Transplant Proc 2004; 36:868-9.
82. Garcia HH, Pretell J, Gilman RH. Neurocysticercosis and the global world. J Neurol 2002; 249:1107-8.
83. Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 1990; 150:325-7.
84. White AC Jr, Tato P, Molinari JL. Host-parasite interactions in Taenia solium cysticercosis. Infect Agents Dis 1992; 1:185-93.
85. Roman G, Sotelo J, Del Brutto O, et al. A proposal to declare neurocysticercosis an international reportable disease. Bull World Health Organ 2000; 78:399-406.
86. Mauad T, Battlehner CN, Bedrikow CL, Capelozzi VL, Saldiva PH. Case report: massive cardiopulmonary cysticercosis in a leukemic patient. Pathol Res Pract 1997; 193:527-9.
87. Sanz CR. Host response in childhood neurocysticercosis: some pathological aspects. Childs Nerv Syst 1987; 3:206-7.
88. Thornton CA, Houston S, Latif AS. Neurocysticercosis and human immunodeficiency virus infection: a possible association. Arch Neurol 1992; 49:963-5.
89. Soto Hernandez JL, Ostrosky Zeichner L, Tavera G, Gomez Avina A. Neurocysticercosis and HIV infection: report of two cases and review. Surg Neurol 1996; 45:57-61.
90. Delobel P, Signate A, El Guedj M, et al. Unusual form of neurocysticercosis associated with HIV infection. Eur J Neurol 2004; 11:55-8.
91. Cook GC. Neurocysticercosis: parasitology, clinical presentation, diagnosis, and recent advances in management. Q J Med 1988; 68:575-83.
92. Del Brutto OH, Santibanez R, Noboa CA, Aguirre R, Diaz E, Alarcon TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992; 42:389-92.
93. Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001; 57:177-83.
94. Richards F Jr, Schantz PM. Laboratory diagnosis of cysticercosis. Clin Lab Med 1991; 11:1011-28.
95. Takayanagui OM, Jardim E. Therapy for neurocysticercosis: comparison between albendazole and praziquantel. Arch Neurol 1992; 49:290-4.
96. Zheng J, Gu XG, Xu YL, et al. Relationship between the transmission of schistosomiasis japonica and the construction of the Three Gorge Reservoir. Acta Trop 2002; 82:147-56.
97. Shokeir AA. Renal transplantation: the impact of schistosomiasis. BJU Int 2001; 88:915-20.
98. Mahmoud HK. Schistosomiasis as a predisposing factor to veno-occlusive disease of the liver following allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 17:401-3.
99. Nobre V, Braga E, Rayes A, et al. Opportunistic infections in patients with AIDS admitted to a university hospital of the Southeast of Brazil. Rev Inst Med Trop Sao Paulo 2003; 45:69-74.
100. Livramento JA, Machado LR, Spina-Franca A. Cerebrospinal fluid abnormalities in 170 cases of AIDS [in Portuguese]. Arq Neuropsiquiatr 1989; 47:326-31.
101. Stuiver PC. Acute schistosomiasis (Katayama fever). Br Med J (Clin Res Ed) 1984; 288:221-2.
102. Pittella JE. Neuroschistosomiasis. Brain Pathol 1997; 7:649-62.
103. Pittella JE. The relation between involvement of the central nervous system in schistosomiasis mansoni and the clinical forms of the parasitosis: a review. J Trop Med Hyg 1991; 94:15-21.
104. Scrimgeour EM, Gajdusek DC. Involvement of the central nervous system in Schistosoma mansoni and S. haematobium infection: a review. Brain 1985; 108:1023-38.
105. File S. Interaction of schistosome eggs with vascular endothelium. J Parasitol 1995; 81:234-8.
106. Rabello AL, Rocha RS, de Oliveira JP, Katz N, Lambertucci JR. Stool examination and rectal biopsy in the diagnosis and evaluation of therapy of schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1992; 34:601-8.
107. Jyding Vennervald B, Kahama AI, Reimert CM. Assessment of morbidity in Schistosoma haematobium infection: current methods and future tools. Acta Trop 2000; 77:81-9.
108. Ferrari TC, Moreira PR, Oliveira RC, Ferrari ML, Gazzinelli G, Cunha AS. The value of an enzyme-linked immunosorbent assay for the diagnosis of schistosomiasis mansoni myeloradiculopathy. Trans R Soc Trop Med Hyg 1995; 89:496-500.
109. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001; 33:1040-7.
110. Vaidian AK, Weiss LM, Tanowitz HB. Chagas' disease and AIDS. Kinetoplastid Biol Dis 2004; 3:2.
111. Fowler R, Lee C, Keystone JS. The role of corticosteroids in the treatment of cerebral schistosomiasis caused by Schistosoma mansoni: case report and discussion. Am J Trop Med Hyg 1999; 61:47-50.
112. Ching HT, Clark AE, Hendrix VJ, Kobrine AI, Schwartz AM. MR imaging appearance of intracerebral schistosomiasis. AJR Am J Roentgenol 1994; 162:693-4.
113. Xiao S, Tanner M, N'Goran EK, et al. Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop 2002; 82:175-81.
114. Ferrari ML, Coelho PM, Antunes CM, Tavares CA, da Cunha AS. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial. Bull World Health Organ 2003; 81:190-6.
115. Correa-Oliveira R, Rodrigues Caldas I, Assis Martins-Filho O, et al. Analysis of the effects of treatment of human Schistosoma mansoni infection on the immune response of patients from endemic areas. Acta Trop 2000; 77:141-6.
116. Watt G, Adapon B, Long GW, Fernando MT, Ranoa CP, Cross JH. Praziquantel in treatment of cerebral schistosomiasis. Lancet 1986; 2:529-32.
117. Karanja DM, Hightower AW, Colley DG, et al. Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study. Lancet 2002; 360:592-6.
118. DeVault GA Jr, King JW, Rohr MS, Landreneau MD, Brown ST III, McDonald JC. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis 1990; 12:653-71.
119. Thompson JR, Berger R. Fatal adult respiratory distress syndrome following successful treatment of pulmonary strongyloidiasis. Chest 1991; 99:772-4.
120. Orlent H, Crawley C, Cwynarski K, Dina R, Apperley J. Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2003; 32:115-7.
121. Schad GA. Cyclosporine may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients. J Infect Dis 1986; 153:178.
122. Celedon JC, Mathur-Wagh U, Fox J, Garcia R, Wiest PM. Systemic strongyloidiasis in patients infected with the human immunodeficiency virus: a report of 3 cases and review of the literature. Medicine (Baltimore) 1994; 73:256-63.
123. Leads from the MMWR: revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. JAMA 1987; 258: 1143-5, 1149, 1153-4.
124. Terashima A, Alvarez H, Tello R, Infante R, Freedman DO, Gotuzzo E. Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection. Int J Infect Dis 2002; 6:28-30.
125. Gotuzzo E, Terashima A, Alvarez H, et al. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg 1999; 60:146-9.
126. Lahn MM, Staub-Schmidt T, Himy R, et al. Strongyloides stercoralis infection in a non-immunosuppressed tourist with involvement of the central nervous system. Trop Geogr Med 1994; 46:368-70.
127. Dutcher JP, Marcus SL, Tanowitz HB, Wittner M, Fuks JZ, Wiernik PH. Disseminated strongyloidiasis with central nervous system involvement diagnosed antemortem in a patient with acquired immunodeficiency syndrome and Burkitts lymphoma. Cancer 1990; 66:2417-20.
128. Neefe LI, Pinilla O, Garagusi VF, Bauer H. Disseminated strongyloidiasis with cerebral involvement: a complication of corticosteroid therapy. Am J Med 1973; 55:832-8.
129. Simpson WG, Gerhardstein DC, Thompson JR. Disseminated Strongyloides stercoralis infection. South Med J 1993; 86:821-5.